VXRT
VXRT clinical trials: Vaxart, Inc.
Every trial on ClinicalTrials.gov where Vaxart, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 24
- Trials linked
- 23
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
VXRT on the catalyst calendar · VXRT registry changes
- Primary completion May 2027Sponsor estimatePhase 2NCT06672055A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in...Vaxart · SARS-CoV2Active, not recruitingVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 14, 2026ActualPhase 1NCT06944717A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years OldVaxart · Norovirus InfectionsCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 13, 2024ActualPhase 1NCT07254728A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing InfantsVaxart · Norovirus InfectionsCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 13, 2023ActualPhase 1/Phase 2NCT05212168Norovirus Challenge StudyVaxart · Norovirus InfectionsCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 16, 2023ActualPhase 2NCT05626803A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy VolunteersVaxart · Norovirus InfectionsCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 10, 2022ActualPhase 2NCT05067933A Ph 2 Trial With an Oral Tableted COVID-19 VaccineVaxart · COVID-19TerminatedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 1, 2022ActualPhase 1NCT05213728A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based...Vaxart · Norovirus InfectionsCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 10, 2021ActualPhase 1NCT04563702Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost...Vaxart · Covid19CompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 30, 2021ActualPhase 1/Phase 2NCT04875676Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus VaccinesVaxart · Norovirus InfectionsCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 4, 2022ActualPhase 1NCT04854746Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus VaccineVaxart · Norovirus InfectionsCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 8, 2017ActualPhase 2NCT02918006A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu VaccineVaxart · InfluenzaCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 15, 2021ActualPhase 1NCT03897309Safety & Immunogenicity Study of Ad5 Based Oral Norovirus VaccinesVaxart · Norovirus InfectionCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 16, 2016ActualPhase 1NCT02830932Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)Vaxart · Respiratory Syncytial Virus (RSV)CompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2018ActualPhase 2NCT02724254A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up...Vaxart · CondylomaCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 1, 2017ActualPhase 1NCT03125473Dose-Optimization Trial of VXA-G1.1-NN in Healthy VolunteersVaxart · Norovirus GastroenteritisCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 5, 2017ActualPhase 1NCT03121339Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy AdultsVaxart · Seasonal Influenza Preventative Vaccine PharmacodynamicsCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 5, 2016ActualPhase 1NCT02868073Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus VaccineVaxart · Norovirus GastroenteritisCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 21, 2016ActualPhase 1NCT02547792Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy AdultsVaxart · Seasonal Influenza BCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2017ActualPhase 2NCT03024177A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus InfectionVaxart · RhinovirusWithdrawnVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2014ActualPhase 1NCT01688297Safety Study of an Oral Vaccine to Prevent Seasonal InfluenzaVaxart · InfluenzaCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2014ActualPhase 1NCT01761123Immunogenicity of Seasonal Influenza by Delivery Directly to IleumVaxart · Seasonal InfluenzaCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2013ActualPhase 1NCT01698060Immunogenicity of ND1.1 by Delivery Directly to the IleumVaxart · Avian InfluenzaCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2012ActualPhase 1NCT01335347Safety Study of an Oral Vaccine to Prevent Avian InfluenzaVaxart · Avian InfluenzaCompletedVXRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 28, 2018ActualPhase 1NCT03721549Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge ModelWCCT Global · Norovirus InfectionCompletedVXRTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 24 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner